Citigroup’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.7M | Buy |
200,000
+150,000
| +300% | +$23.1M | 0.01% | 822 |
|
|
2025
Q4 | $8.7M | Sell |
50,000
-107,000
| -68% | -$19.5M | ﹤0.01% | 1645 |
|
|
2025
Q3 | $22.6M | Buy |
+157,000
| New | +$19.2M | 0.01% | 992 |
|
|
2024
Q3 | – | Sell |
-25,000
| Closed | -$1.68M | – | 5732 |
|
|
2024
Q2 | $1.68M | Sell |
25,000
-130,600
| -84% | -$5.07M | ﹤0.01% | 2498 |
|
|
2024
Q1 | $4.22M | Buy |
155,600
+100,600
| +183% | +$2.82M | ﹤0.01% | 1827 |
|
|
2023
Q4 | $1.7M | Buy |
+55,000
| New | +$1.43M | ﹤0.01% | 2379 |
|
|
2023
Q2 | – | Sell |
-29,800
| Closed | -$508K | – | 5639 |
|
|
2023
Q1 | $508K | Buy |
29,800
+5,000
| +20% | +$97.1K | ﹤0.01% | 3117 |
|
|
2022
Q4 | $496K | Buy |
+24,800
| New | +$479K | ﹤0.01% | 3178 |
|
|
2020
Q4 | – | Sell |
-3,200
| Closed | -$103K | – | 7486 |
|
|
2020
Q3 | $103K | Sell |
3,200
-3,500
| -52% | -$101K | ﹤0.01% | 5084 |
|
|
2020
Q2 | $185K | Buy |
6,700
+1,000
| +18% | +$23.7K | ﹤0.01% | 5069 |
|
|
2020
Q1 | $91K | Sell |
5,700
-6,700
| -54% | -$159K | ﹤0.01% | 5411 |
|
|
2019
Q4 | $296K | Sell |
12,400
-6,100
| -33% | -$124K | ﹤0.01% | 4865 |
|
|
2019
Q3 | $326K | Buy |
18,500
+15,700
| +561% | +$303K | ﹤0.01% | 4742 |
|
|
2019
Q2 | $72K | Sell |
2,800
-1,500
| -35% | -$41.8K | ﹤0.01% | 6154 |
|
|
2019
Q1 | $125K | Buy |
4,300
+2,900
| +207% | +$75.2K | ﹤0.01% | 5538 |
|
|
2018
Q4 | $18K | Sell |
1,400
-1,400
| -50% | -$22.3K | ﹤0.01% | 6927 |
|
|
2018
Q3 | $57K | Buy |
2,800
+2,500
| +833% | +$56.5K | ﹤0.01% | 6406 |
|
|
2018
Q2 | $7K | Sell |
300
-7,000
| -96% | -$180K | ﹤0.01% | 7280 |
|
|
2018
Q1 | $164K | Sell |
7,300
-32,600
| -82% | -$858K | ﹤0.01% | 5167 |
|
|
2017
Q4 | $1.24M | Sell |
39,900
-21,600
| -35% | -$638K | ﹤0.01% | 3130 |
|
|
2017
Q3 | $1.92M | Buy |
61,500
+55,800
| +979% | +$1.06M | ﹤0.01% | 2700 |
|
|
2017
Q2 | $98K | Buy |
5,700
+4,100
| +256% | +$70K | ﹤0.01% | 5355 |
|
|
2017
Q1 | $28K | Sell |
1,600
-14,500
| -90% | -$224K | ﹤0.01% | 6073 |
|
|
2016
Q4 | $213K | Sell |
16,100
-200
| -1% | -$2.73K | ﹤0.01% | 5227 |
|
|
2016
Q3 | $237K | Buy |
16,300
+9,200
| +130% | +$115K | ﹤0.01% | 4524 |
|
|
2016
Q2 | $70K | Buy |
7,100
+700
| +11% | +$8.17K | ﹤0.01% | 5351 |
|
|
2016
Q1 | $81K | Buy |
6,400
+5,900
| +1,180% | +$77.6K | ﹤0.01% | 5817 |
|
|
2015
Q4 | $9K | Buy |
+500
| New | +$8.81K | ﹤0.01% | 6859 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Citigroup's INSM Position: Q1 2026 in Review
Citigroup reduced its Insmed (INSM) stake by 1.9% in Q1 2026, selling an estimated $709K and leaving 233,304 shares worth $38.1M. The position accounts for 0.02% of the portfolio, ranked #753.
Citigroup first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. The position peaked at $41.4M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Citigroup held 233,304 shares of Insmed worth $38.1M as of Q1 2026.
- Citigroup sold 4,610 Insmed shares in Q1 2026, an estimated $709K.
- Insmed made up 0.02% of Citigroup's portfolio in Q1 2026, its #753 holding.
- Citigroup first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Insmed position peaked at $41.4M in Q4 2025.
- 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.